Literature DB >> 23306726

Can early postoperative intraocular pressure predict success following mitomycin-C augmented trabeculectomy in primary angle-closure glaucoma.

S S Rong1, M Y Feng, N Wang, H Meng, R Thomas, S Fan, R Wang, X Wang, X Tang, Y B Liang.   

Abstract

PURPOSE: To evaluate the association between early and late postoperative intraocular pressure (IOP) and determine if early postoperative IOP can predict the surgical outcome.
METHODS: A total of 165 consecutive patients with primary angle-closure glaucoma (PACG) undergoing primary mitomycin-C-augmented trabeculectomy underwent a comprehensive eye examination before surgery and were followed-up on days 1, 7, 14, and 30, and months 3, 6, 12, and 18. IOPs on days 1, 7, 14, and 30 were stratified into groups A (<10 mm Hg), B (≥10 and <15 mm Hg), C (≥15 and <20 mm Hg), and D (≥20 mm Hg). Differences between groups were analyzed using analysis of variance (ANOVA) and Fisher's exact test. Multivariable regression was used to exam the predictive ability of early IOP for final outcome.
RESULTS: The mean age was 62.5±7.9 years and 41.21% (n=68) were males. Stratified by IOP on days 1, 7, 14, and 30, respectively, mean IOPs at month 18 were different among groups A, B, C, and D (ANOVA, P=0.047, P=0.033, P=0.008, and P<0.001, respectively). Once the IOPs were settled with interventions on day 7 a higher IOP level was associated with decreasing success rate under different outcome definitions, final IOP <15 mm Hg (Fisher's exact P=0.001) and <20 mm Hg (P=0.039) without medication. Multiple regression showed early IOP predicted final IOP independently from baseline variables. A cutoff value of 13.5 mm Hg on day 7 achieved an accuracy of 80.0 and 57.1% in predicting IOP<15 mm Hg without medication and failure after surgery, respectively.
CONCLUSIONS: The IOP at 18 months following primary antifibrotic-augmented trabeculectomy in PACG patients is associated with and predicted by the postoperative IOPs at 1 month. Control of early IOP to 13.5 or less may provide better outcomes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306726      PMCID: PMC3597889          DOI: 10.1038/eye.2012.291

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  22 in total

1.  The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

Authors: 
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

2.  The predictive value of post-operative intraocular pressures following trabeculectomy.

Authors:  S M Downes; G P Mission; H S Jones; E C O'Neill
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

3.  Postoperative prognostic indicators following trabeculectomy.

Authors:  W C Stewart; R A Pitts
Journal:  Acta Ophthalmol (Copenh)       Date:  1993-12

4.  Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma.

Authors:  C O'Brien; B Schwartz; T Takamoto; D C Wu
Journal:  Am J Ophthalmol       Date:  1991-04-15       Impact factor: 5.258

5.  Target intraocular pressure for stability of visual field loss progression in normal-tension glaucoma.

Authors:  Akira Aoyama; Kyoko Ishida; Akira Sawada; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2010-04-18       Impact factor: 2.447

6.  Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head.

Authors:  W C Stewart; R P Chorak; H H Hunt; G Sethuraman
Journal:  Am J Ophthalmol       Date:  1993-08-15       Impact factor: 5.258

7.  Long-term evaluation of trabeculectomy in primary open angle glaucoma and chronic primary angle closure glaucoma in an Asian population.

Authors:  Ramanjit Sihota; Viney Gupta; Harish C Agarwal
Journal:  Clin Exp Ophthalmol       Date:  2004-02       Impact factor: 4.207

8.  Association between intraocular pressure and loss of visual field in chronic simple glaucoma.

Authors:  R Vogel; R P Crick; R B Newson; M Shipley; H Blackmore; C J Bulpitt
Journal:  Br J Ophthalmol       Date:  1990-01       Impact factor: 4.638

9.  A prospective longterm study of primary chronic angle closure glaucoma.

Authors:  Ramanjit Sihota; Aman Sood; Viney Gupta; Vishal Gupta; Tanuj Dada; Harish C Agarwal
Journal:  Acta Ophthalmol Scand       Date:  2004-04

10.  Intensified postoperative care versus conventional follow-up: a retrospective long-term analysis of 177 trabeculectomies.

Authors:  Dirk Marquardt; Wolfgang E Lieb; Franz Grehn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-26       Impact factor: 3.117

View more
  5 in total

1.  One-month IOP in mitomycin C-augmented trabeculectomy can predict long-term IOP control in chronic primary angle-closure glaucoma.

Authors:  Chengguo Zuo; Shufen Lin; Keling Wu; Ruowen Gong; Yafen Liu; Mingkai Lin; Jian Ge
Journal:  Int Ophthalmol       Date:  2019-01-24       Impact factor: 2.031

2.  Primary angle-closure glaucoma: A retrospective interventional case series in South India.

Authors:  H H Suresh; H R Samhitha; H Kishore; Krishna Prasad; Sneha Solse; P Divya
Journal:  Oman J Ophthalmol       Date:  2016 Jan-Apr

3.  Is a Day 1 postoperative review following ab interno Xen gel stent surgery for glaucoma needed?

Authors:  Ayesha Karimi; Dan Lindfield
Journal:  Clin Ophthalmol       Date:  2018-11-15

4.  Predictive value of early postoperative IOP and bleb morphology in Mitomycin-C augmented trabeculectomy.

Authors:  Hamed Esfandiari; Mohammad Pakravan; Nils A Loewen; Mehdi Yaseri
Journal:  F1000Res       Date:  2017-10-27

5.  First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery.

Authors:  Norbert Pfeiffer; Bogomil Voykov; Giulia Renieri; Katharina Bell; Paul Richter; Melanie Weigel; Hagen Thieme; Barbara Wilhelm; Katrin Lorenz; Martin Feindor; Katja Wosikowski; Michel Janicot; Daniela Päckert; Regina Römmich; Carola Mala; Petra Fettes; Eugen Leo
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.